Expanding Innovative Screening Methods Keeps Jim Plante Busy in the Research Field

15

Pathway Genomics has led the medical field in offering innovative testing and state-of-the-art screening procedures designed not only for the medical community but for individuals as well. The company was founded in 2008 by its President and CEO, Jim Plante. For over two decades, Plante has been an entrepreneur involved in a wide variety of endeavors. Many of these efforts have centered on investments in the medical research and technology fields, so it is not surprising that Pathway would focus on ways to incorporate the two.

Plante graduated from Southern Illinois University at Carbondale where he received a degree in Electrical Engineering. Many of his efforts in biotechnology were encouraged by watching his father struggle with polycystic kidney disease. This genetic disorder has been known to Plante for over 30 years, and his efforts with Pathway Genomics offer hope of finding methods of faster diagnosis, discovering more effective treatments, and even developing solutions that could lead to the future eradication of these types of medical concerns.

His lengthy resume includes serving as the President of notable companies like Bel-Tronics, E-Band Communications, and Smart Drive Systems. He has served as a committee member of the International Trade Advisory for the United States Department of Commerce. Plante is currently a Board Trustee for the U.K. non-profit research firm, Biogerontology Research Foundation and is also the founder of the Foundation for Kidney Transplant Research. Plante is currently the manager of Plante Capital. This investment firm focuses on providing funding for companies involved in research projects in the healthcare and technology industries.

Under Plante’s supervision, Pathway Genomics is currently expanding the availability of their at-home DNA testing to make it possible for anyone to obtain their complete genetic profile. This information will provide the user with a clear understanding of their health risks, their needs, and how their own unique DNA can be used to live a longer and healthier life. The company has designed a groundbreaking app that uses artificial intelligence to create an interactive experience for users. The app makes it possible for people to stay attuned to their current well-being and receive detailed health and wellness advice tailored specifically for them based on their personal health information.